Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment
Crossref DOI link: https://doi.org/10.1186/s13075-015-0778-z
Published Online: 2015-09-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nasrallah, Mazen
Pouliot, Yannick
Hartmann, Bjoern
Dunn, Patrick
Thomson, Elizabeth
Wiser, Jeffrey
Butte, Atul J.